Characterization of mutations in patients with autoimmune polyglandular syndrome type 1 (APS1)

Asplenia and functional hyposplenism in

Asplenia and functional hyposplenism in autoimmune polyglandular syndrome type 1

✍ Uri Pollak; Zvi Bar-Sever; Vered Hoffer; Nufar Marcus; Oded Scheuerman; Ben Zion 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 80 KB

Reversible hyperkinesia in a patient wit

Reversible hyperkinesia in a patient with autoimmune polyglandular syndrome type I

✍ Baumert, T. ;Kleber, G. ;Schwarz, J. ;St�bler, A. ;Lamerz, R. ;Mann, K. 📂 Article 📅 1993 🏛 Springer-Verlag 🌐 English ⚖ 554 KB

Autoimmune polyglandular syndrome is characterized by a failure of multiple endocrine organs and the presence of circulating organ-specific autoantibodies targeted against the failing organs. Here we describe a patient with autoimmune polyglandular syndrome type I with the endocrine manifestations o

Polyglandular autoimmune syndrome type 3

Polyglandular autoimmune syndrome type 3 in a patient with ocular myasthenia gravis

✍ Natalie K. Briscoe; Michelle M. Mezei 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 44 KB

Autoantibodies in autoimmune polyglandul

Autoantibodies in autoimmune polyglandular syndrome type I patients react with major brain neurotransmitter systems

✍ Sergueï O. Fetissov; Sophie Bensing; Jan Mulder; Erwan Le Maitre; Anna-Lena Hult 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 321 KB

## Abstract Patients with autoimmune polyglandular syndrome type I (APS1) often display high titers of autoantibodies (autoAbs) directed against aromatic L‐amino acid decarboxylase (AADC), tyrosine hydroxylase (TH), tryptophan hydroxylase (TPH), and glutamic acid decarboxylase (GAD). Neurological s

Autoantibodies in autoimmune polyglandul

Autoantibodies in autoimmune polyglandular syndrome type I patients react with major brain neurotransmitter systems

✍ Sergueï O. Fetissov; Sophie Bensing; Jan Mulder; Erwan Le Maitre; Anna-Lena Hult 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 320 KB

## Abstract Patients with autoimmune polyglandular syndrome type I (APS1) often display high titers of autoantibodies (autoAbs) directed against aromatic L‐amino acid decarboxylase (AADC), tyrosine hydroxylase (TH), tryptophan hydroxylase (TPH), and glutamic acid decarboxylase (GAD). Neurological s

An 8-year-old boy with autoimmune hepati

An 8-year-old boy with autoimmune hepatitis and Candida onychosis as the first symptoms of autoimmune polyglandular syndrome (APS1): identification of a new homozygous mutation in the autoimmune regulator gene (aire)

✍ Carla Lintas; Marco Cappa; Donatella Comparcola; Valerio Nobili; Alessandra Fier 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 190 KB